Magenta Therapeutics, Inc.
MGTA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2,733 | $2,733 | $2,733 | $2,733 |
| - Cash | $55,984 | $13,237 | $10,116 | $22,792 |
| + Debt | $1,285 | $1,330 | $1,396 | $1,491 |
| Enterprise Value | -$51,966 | -$9,174 | -$5,987 | -$18,568 |
| Revenue | $396 | $193 | $1,163 | $6,235 |
| % Growth | 105.2% | -83.4% | -81.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 0% | 0% | 0% | 0% |
| EBITDA | -$36,666 | -$34,927 | -$33,177 | -$35,960 |
| % Margin | -9,259.1% | -18,096.9% | -2,852.7% | -576.8% |
| Net Income | -$36,765 | -$31,629 | -$29,511 | -$32,337 |
| % Margin | -9,284.1% | -16,388.1% | -2,537.5% | -518.6% |
| EPS Diluted | -9.41 | -8.1 | -7.55 | 13.02 |
| % Growth | -16.2% | -7.3% | -158% | – |
| Operating Cash Flow | -$30,555 | -$23,892 | -$27,630 | -$19,349 |
| Capital Expenditures | -$5 | -$46 | -$24 | $296 |
| Free Cash Flow | -$30,560 | -$23,938 | -$27,654 | -$19,053 |